Bay R 1531

Bay R 1531
Clinical data
Other names	LY-197206; LY197206; 4,α-Methylene-5-methoxy-N,N-dipropyltryptamine; 4,α-Methylene-5-MeO-DPT
Drug class	Serotonin 5-HT1A receptor agonist; Simplified/partial LSD analogue
ATC code	None;
Identifiers
	IUPAC name 1,3,4,5-tetrahydro-6-methoxy-N,N-dipropyl-benz[cd]indol-4-amine;
CAS Number	98770-54-8;
PubChem CID	127153;
PubChem SID	274136915;
ChemSpider	112872;
CompTox Dashboard (EPA)	DTXSID80913088 ;
Chemical and physical data
Formula	C18H26N2O
Molar mass	286.419 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc2ccc1[nH]cc3CC(Cc2c13)N(CCC)CCC;
	InChI InChI=1S/C18H26N2O/c1-4-8-20(9-5-2)14-10-13-12-19-16-6-7-17(21-3)15(11-14)18(13)16/h6-7,12,14,19H,4-5,8-11H2,1-3H3; Key:BMZWFSGTPJUKJR-UHFFFAOYSA-N;

Bay R 1531, also known as LY-197206 or as 4,α-methylene-5-MeO-DPT, is a tricyclic tryptamine derivative. It acts as a selective serotonin 5-HT_1A receptor agonist. It was investigated unsuccessfully for the treatment of stroke but continues to be used in scientific research. It shows very high affinity for the serotonin 5-HT_1A receptor (K_i = 1.3 nM).